Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers
Accurate staging of prostate cancer (PCa) at initial diagnosis and at biochemical recurrence is important to determine prognosis and the optimal treatment strategy. To date, treatment of metastatic PCa has mostly been based on the results of conventional imaging with abdominopelvic computed tomograp...
Main Authors: | Wietske I. Luining, Dennie Meijer, Max R. Dahele, André N. Vis, Daniela E. Oprea-Lager |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/1/117 |
Similar Items
-
Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy
by: Helle D. Zacho, et al.
Published: (2020-04-01) -
Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases
by: Flavian Tabotta, et al.
Published: (2019-12-01) -
Assessment of Bone Metastases in Patients with Prostate Cancer—A Comparison between 99mTc-Bone-Scintigraphy and [68Ga]Ga-PSMA PET/CT
by: Lena Thomas, et al.
Published: (2017-07-01) -
A prospective study determining and comparing the diagnostic accuracy of fluoride-PET/CT, choline-PET/CT, whole-body bone SPECT/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer
by: Eva Dyrberg, et al.
Published: (2018-10-01) -
Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
by: Nicolas de Leiris, et al.
Published: (2020-08-01)